Ridgecrest Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Ridgecrest Wealth Partners's AMGN Position: Q2 2026 in Review
Ridgecrest Wealth Partners increased its Amgen (AMGN) stake by 2.5% in Q2 2026, buying an estimated $35.6K and bringing the position to 4,325 shares worth $1.57M. The position accounts for 0.76% of the portfolio, ranked #28.
Ridgecrest Wealth Partners first reported a position in AMGN in Q1 2021 and has held it in 22 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Ridgecrest Wealth Partners held 4,325 shares of Amgen worth $1.57M as of Q2 2026.
- Ridgecrest Wealth Partners bought 104 Amgen shares in Q2 2026, an estimated $35.6K.
- Amgen made up 0.76% of Ridgecrest Wealth Partners's portfolio in Q2 2026, its #28 holding.
- Ridgecrest Wealth Partners first reported a position in Amgen in Q1 2021 and has held it in 22 quarters since.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Ridgecrest Wealth Partners's 13F filing for Q2 2026, filed 5 Aug 2026.